SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-116454
Filing Date
2014-03-26
Accepted
2014-03-26 16:05:10
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d658575d10k.htm 10-K 1379935
2 EX-21.1 d658575dex211.htm EX-21.1 1805
3 EX-23.1 d658575dex231.htm EX-23.1 1221
4 EX-31.1 d658575dex311.htm EX-31.1 8345
5 EX-31.2 d658575dex312.htm EX-31.2 8341
6 EX-32.1 d658575dex321.htm EX-32.1 3148
7 EX-32.2 d658575dex322.htm EX-32.2 3158
14 GRAPHIC g658575g24b56.jpg GRAPHIC 85233
  Complete submission text file 0001193125-14-116454.txt   11266453

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT petx-20131231.xml EX-101.INS 1370527
9 XBRL TAXONOMY EXTENSION SCHEMA petx-20131231.xsd EX-101.SCH 110414
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE petx-20131231_cal.xml EX-101.CAL 124570
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE petx-20131231_def.xml EX-101.DEF 478314
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE petx-20131231_lab.xml EX-101.LAB 793786
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE petx-20131231_pre.xml EX-101.PRE 669520
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35952 | Film No.: 14718690
SIC: 2834 Pharmaceutical Preparations